HLA-B gene participates in the NF-κB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1453-1459

  Guo, Yan ^a   Liu, Jia ^a   Xu, Zhenming ^b   Sun, Kailai ^a   Fu, Weineng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b The 463 Hospital of Chinese PLA   (China)

Author keywords

Apoptosis; HLA B; Laryngeal carcinoma; NF B signal pathway

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CALGRANULIN A; HLA B ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOASSAY; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CANCER INVASION; CELL CULTURE; CELL CYCLE; GENETICS; LARYNX TUMOR; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALGRANULIN A; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; HLA-B ANTIGENS; HUMANS; LARYNGEAL NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NF-KAPPA B; NIH 3T3 CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 48849115264     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
2. Busquets JM, Garcia HA, Trinidad-Pinedo J and Baez A: Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans. P R Health Sci J 22: 259-264, 2003.
3. Garcia-Lora A, Algarra I, Collado A and Garrido F: Tumor immunology, vaccination and escape strategies. Eur J Immunogenet 30: 177-183, 2003.
4. Hicklin DJ, Marincola FM and Ferrone S: HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 5: 178-186, 1999.
5. Marincola FM, Jaffee EM, Hicklin DJ and Ferrone S: Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74: 181-273, 2000.
6. Chang CC, Campoli M and Ferrone S: Classical and nonclassical HLA class I antigen and NK cell-activating ligand changes in malignant cells: current challenges and future directions. Adv Cancer Res 93: 189-234, 2005.
7. Fu W, Guo Y, Huang D, Shang C and Sun K: Novel partners of S100A8 identified in laryngeal cancer cell lines. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 266-270, 2007.
8. Towbin H, Staehelin T and Gordoh J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
9. Puppo F, Scudeletti M, Indiveri F and Ferrone S: Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 17: 99-100, 1995.
10. Puppo F, Indiveri F, Scudeletti M and Ferrone S: Soluble HLA antigens: new roles and uses. Immunol Today 18: 154-155, 1997.
11. Bangia N and Ferrone S: Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes? Immunol Invest 35: 485-503, 2006.
12. Rockett JC, Darnton SJ, Crocker J, Matthews HR and Morris AG: Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin Pathol 48: 539-544, 1995.
13. Cabrera T, Maleno I, Lopez-Nevot MA, Redondo M, Fernandez MA, Collado A and Garrido F: High frequency of HLA-B44 allelic losses in human solid tumors. Hum Immunol 64: 941-950, 2003.
14. Cabrera T, Salinero J, Fernandez MA, Garrido A, Esquivias J and Garrido F: High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol 61: 499-506, 2000.
15. Ogoshi K, Tajima T, Mitomi T and Tsuji K: HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer. Clin Exp Metastasis 14: 277-281, 1996.
16. Cabrera T, Angustias Fernandez M, Sierra A, Garrido A, Herruzo A, Escobedo A, Fabra A and Garrido F: High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol 50: 127-134, 1996.
17. Esteban F, Concha A, Delgado M, Pérez-Ayala M, Ruiz-Cabello F and Garrido F: Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer 62: 1047-1051, 1990.
18. Kerkhoff C, Klempt M and Sorg C: Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1448: 200-211, 1998.
19. Ludwig S, Stephan C, Lein M, Loening SA and Jung K: S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study. Prostate 67: 1301-1307, 2007.
20. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R and Cheng L: The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 22: 1025-1032, 2007.
21. Gebhardt C, Németh J, Angel P and Hess J: S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72: 1622-1631, 2006.
22. Gobin SJ, Keijsers V, van Zutphen M and van den Elsen PJ: The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol 161: 2276-2283, 1998.
23. Coultas L and Strasser A: The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 13: 115-123, 2003.
24. Puppo F, Contini P, Ghio M, Brenci S, Scudeletti M, Filaci G, Ferrone S and Indiveri F: Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol 12:195-203, 2000.
25. Zavazava N and Kronke M: Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 2: 1005-1010, 1996.
26. + cytotoxic T lymphocytes by Fas/Fas-ligand interaction. Hum Immunol 61: 1347-1351, 2000.
27. + cells by Fas/Fas-ligand interaction. Scient World J 12: 421-423, 2002.
28. Ruiz-Cabello F and Garrido F: Escape from tumor recognition. In: Primer on Tumor Immunology. Parmiani G and Lotze M (eds). Harwood Academic Publishers GmbH, Amsterdam, 2000.
29. Ruiz-Cabello F and Garrido F: HLA and cancer: from research to clinical impact. Immunol Today 19: 539-542, 1998.